Aarti Pharmalabs Limited - Company Profile

It is a pharma public limited company based in Vapi, Gujarat, India, established in 2019.
2019 Vapi, Gujarat, India Active
Last Updated:
Access Report
About Aarti Pharmalabs Limited

Aarti Pharmalabs Limited, a active public limited company, was established on 22 November 2019 in Vapi, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24100GJ2019PLC110964. Registered under ROC Roc Ahmedabad. it is listed on BSE: 543748. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹45.32 Cr.

Formerly known as Aarti Organics Limited. It upholds a compliant status. In 2024, it reported revenue of ₹1,513.14 Cr and a net worth of ₹1,621.46 Cr. Employing 2,004 professional, Its leadership includes Vinay Gopal Nayak (Director), Nehal Garewal (Director), Hetal Gogri Gala (Managing Director). Past directors included Vinay Gopal Nayak, Nehal Garewal, Hetal Gogri Gala. It holds ₹400.00 Cr open charges and ₹75.00 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 22/C/1 & 22/C/2, 1St Phase, G.I.D.C. Vapi,, Vapi, Gujarat, 396195.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24100GJ2019PLC110964

  • Registration Number

    110964

  • Incorporation Date

    22 November 2019

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹45.32 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 543748)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 45.32 Cr
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 400.00 Cr
  • Satisfied Charges ₹ 75.00 Cr
  • Revenue Growth **** 0.04%
  • Profit Growth **** 16.84%
  • Ebitda **** 12.27%
  • Net Worth 12.71%
  • Total Assets **** 16.99%
Company report

Aarti Pharmalabs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aarti Pharmalabs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aarti Pharmalabs Limited?
Current Directors
Name Designation Appointment Date Status
Vinay Gopal Nayak Director 17 Oct 2022 Current
Nehal Garewal Director 13 May 2024 Current
Hetal Gogri Gala Managing Director 07 Aug 2021 Current
Rashesh Chandrakant Gogri Director 07 Aug 2021 Current
Bhavesh Rasiklal Vora Director 17 Oct 2022 Current
Jeenal Kenil Savla Director 17 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 23 Feb 2023 Past
Pramod Abcsdd Additional Director 06 Aug 2024 Past
Pramod Abcsdd Director 17 Oct 2022 Past
Pramod Abcsdd Additional Director 27 Sep 2021 Past
Pramod Abcsdd Director 17 Oct 2022 Past
Pramod Abcsdd Additional Director 23 Feb 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aarti Pharmalabs.

Aarti Pharmalabs Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.04% increase. The company also saw a substantial improvement in profitability, with a 16.84% increase in profit. The company's net worth Soared by an impressive increase of 12.71%.

Aarti Pharmalabs revenue growth over time
Aarti Pharmalabs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.04%
*******
*******
*******
*******
Revenue from Operations
*******
 -0.60%
*******
*******
*******
*******
Total Assets
*******
 16.99%
*******
*******
*******
*******
Profit or Loss
*******
 16.84%
*******
*******
*******
*******
Net Worth
*******
 12.71%
*******
*******
*******
*******
EBITDA
*******
 12.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aarti Pharmalabs?

In 2024, Aarti Pharmalabs had a promoter holding of 8.61% and a public holding of 91.40%. The company had 1 Subsidiary and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000,000.00

Satisfied Charges

₹750,000,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 100.00 Cr
  • Idbi Bank Limited : 75.00 Cr
  • Axis Bank Limited : 75.00 Cr
  • Standard Chartered Bank : 75.00 Cr
  • Others : 75.00 Cr
Latest Charge Details
Date Lender Amount Status
17 Mar 2025 Idbi Bank Limited ₹75.00 Cr Open
08 Sep 2024 Citi Bank N.A. ₹70.00 Cr Open
08 Sep 2024 Citi Bank N.A. ₹30.00 Cr Open
09 Feb 2023 Axis Bank Limited ₹75.00 Cr Open
11 Jan 2023 Standard Chartered Bank ₹75.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Aarti Pharmalabs?

Aarti Pharmalabs has a workforce of 2004 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aarti Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarti Pharmalabs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aarti Pharmalabs
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 28 Mar 2023 via Charge ID 100699468 with Sbicap Trustee Company Limited was fully satisfied on 09 Oct 2025. was completed.

  • Annual General Meeting

    Progress on Aarti Pharmalabs Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Aarti Pharmalabs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge with Idbi Bank Limited amounted to Rs. 75.00 Cr with Charge ID 101072057 was registered on 17 Mar 2025. was documented.

  • Charges

    Progress on A charge with Citi Bank N.A. amounted to Rs. 70.00 Cr with Charge ID 100995906 was registered on 08 Sep 2024. was documented.

  • Charges

    A charge with Citi Bank N.A. amounted to Rs. 30.00 Cr with Charge ID 100995900 was registered on 08 Sep 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Aarti Pharmalabs Limited?

The CIN of Aarti Pharmalabs Limited is L24100GJ2019PLC110964.

Where is Aarti Pharmalabs Limited headquartered?

Aarti Pharmalabs Limited is headquartered at Plot No. 22/C/1 & 22/C/2, 1St Phase, G.I.D.C. Vapi,, Vapi, Gujarat, 396195.

When was Aarti Pharmalabs Limited incorporated?

Aarti Pharmalabs Limited was incorporated on 22 November 2019.

Who are the current directors of Aarti Pharmalabs Limited?

The current directors of Aarti Pharmalabs Limited are

What is the primary industry of Aarti Pharmalabs Limited?

The primary industry of Aarti Pharmalabs Limited is Manufacturing.

Is Aarti Pharmalabs Limited a listed company?

Aarti Pharmalabs Limited is listed. It is listed on BSE: 543748.

What is the capital structure of Aarti Pharmalabs Limited?

The authorized capital of Aarti Pharmalabs Limited is ₹50.00 Cr, and the paid-up capital is ₹45.32 Cr.

What is the compliance status of Aarti Pharmalabs Limited?

The compliance status of Aarti Pharmalabs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available